Collectively, our observations derived in several independent, but complementing mouse and human‐derived model systems provide orthogonal evidence for the in vivo effects of bazedoxifene in suppressing the growth of Apc‐driven cancers, most likely through a process involving the inhibition of IL11 signaling in epithelial tumor cells. Here, IL11 is linked to cancer.